Dr. Daniel Tang has been named general manager, Asia Pacific for ICON plc’s Development Solutions business. Dr. Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with Key Opinion Leaders for early phase clinical testing.   Dr. Tang has more than 15 years’ experience in drug research, especially in regulated bioanalysis. Prior to joining ICON, he was vice president of Operations...